TINZAPARIN: 1,720 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
1,720
Total FAERS Reports
276 (16.0%)
Deaths Reported
1,002
Hospitalizations
1,720
As Primary/Secondary Suspect
164
Life-Threatening
16
Disabilities
Jul 14, 2000
FDA Approved
Discontinued
Status
Active Ingredient: TINZAPARIN SODIUM · FDA Application: 020484 ·
First Report: 20010324 · Latest Report: 20250825
What Are the Most Common TINZAPARIN Side Effects?
#1 Most Reported
Acute kidney injury
135 reports (7.8%)
#2 Most Reported
Anaemia
118 reports (6.9%)
#3 Most Reported
Off label use
110 reports (6.4%)
All TINZAPARIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 135 | 7.9% | 20 | 61 |
| Anaemia | 118 | 6.9% | 17 | 75 |
| Off label use | 110 | 6.4% | 3 | 47 |
| Maternal exposure during pregnancy | 108 | 6.3% | 0 | 64 |
| Thrombocytopenia | 86 | 5.0% | 14 | 54 |
| Drug ineffective | 82 | 4.8% | 36 | 63 |
| Toxic epidermal necrolysis | 80 | 4.7% | 15 | 18 |
| Hepatocellular injury | 70 | 4.1% | 7 | 46 |
| Premature baby | 70 | 4.1% | 1 | 48 |
| Cholestasis | 67 | 3.9% | 10 | 44 |
| Dyspnoea | 63 | 3.7% | 1 | 56 |
| Product use in unapproved indication | 61 | 3.6% | 1 | 14 |
| Diarrhoea | 59 | 3.4% | 4 | 47 |
| Premature delivery | 55 | 3.2% | 0 | 47 |
| Haematoma | 50 | 2.9% | 8 | 40 |
| Anxiety | 49 | 2.9% | 0 | 47 |
| Contraindicated product administered | 49 | 2.9% | 42 | 31 |
| Foetal exposure during pregnancy | 48 | 2.8% | 7 | 15 |
| Pyrexia | 46 | 2.7% | 2 | 45 |
| Rectal haemorrhage | 46 | 2.7% | 6 | 29 |
Who Reports TINZAPARIN Side Effects? Age & Gender Data
Gender: 48.5% female, 51.5% male. Average age: 59.6 years. Most reports from: FR. View detailed demographics →
Is TINZAPARIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 1 |
| 2006 | 41 | 0 | 0 |
| 2007 | 3 | 2 | 0 |
| 2008 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 15 | 2 | 12 |
| 2013 | 5 | 0 | 3 |
| 2014 | 28 | 4 | 22 |
| 2015 | 52 | 14 | 34 |
| 2016 | 46 | 10 | 35 |
| 2017 | 135 | 24 | 116 |
| 2018 | 128 | 26 | 56 |
| 2019 | 220 | 29 | 142 |
| 2020 | 117 | 25 | 68 |
| 2021 | 152 | 61 | 83 |
| 2022 | 99 | 5 | 69 |
| 2023 | 105 | 33 | 42 |
| 2024 | 141 | 13 | 76 |
| 2025 | 50 | 4 | 22 |
What Is TINZAPARIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 414 |
| Thrombosis prophylaxis | 229 |
| Pulmonary embolism | 174 |
| Atrial fibrillation | 114 |
| Deep vein thrombosis | 109 |
| Prophylaxis | 78 |
| Anticoagulant therapy | 75 |
| Thrombosis | 51 |
| Ill-defined disorder | 40 |
| Venous thrombosis | 35 |
TINZAPARIN vs Alternatives: Which Is Safer?
TINZAPARIN vs TIOCONAZOLE
TINZAPARIN vs TIOPRONIN
TINZAPARIN vs TIOTROPIUM
TINZAPARIN vs TIPIRACIL\TRIFLURIDINE
TINZAPARIN vs TIPRANAVIR
TINZAPARIN vs TIRAGOLUMAB
TINZAPARIN vs TIRBANIBULIN
TINZAPARIN vs TIROFIBAN
TINZAPARIN vs TIRZEPATIDE
TINZAPARIN vs TISAGENLECLEUCEL
Official FDA Label for TINZAPARIN
Official prescribing information from the FDA-approved drug label.